Entrada Therapeutics, Inc. (TRDA)

Last Three Months

22-Aug-24 -- 21-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

14

0

0

+1

0

+2

0

+3

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
10-Sep-24 4:34 PM View:	09-Sep-24 Private Sale (Planned) ($47.83K)	Wentworth Kory James Chief Financial Officer		Entrada Therapeutics, Inc. - TRDA	(6%) 81.41K to 76.49K	0	0	--	--	Show Txns Hide Txns

10-Sep-24 4:32 PM View:	09-Sep-24 Sale (Planned) ($39.86K)	Sethuraman Natarajan Chief Scientific Officer		Entrada Therapeutics, Inc. - TRDA	(3%) 188.81K to 183.82K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 6:49 PM View:	05-Sep-24 Payment of Exercise ($12.49K)	Doshi Dipal CEO Director		Entrada Therapeutics, Inc. - TRDA	(3%) 334.48K to 325.75K	0	0	--	--	Show Txns Hide Txns

30-Sep-24 4:32 PM View:	26-Sep-24 Private Sale (Planned) ($13.55K)	Dowden Nathan J President & COO		Entrada Therapeutics, Inc. - TRDA	(4%) 130.11K to 125.15K	0	0	--	--	Show Txns Hide Txns